主管:国家卫生健康委员会
主办:国家卫生健康委医院管理研究所
中国科技核心期刊(中国科技论文统计源期刊)
中国科学引文数据库(CSCD)核心库期刊
《中文核心期刊要目总览》核心期刊

中国护理管理 ›› 2026, Vol. 26 ›› Issue (2): 273-278.doi: 10.3969/j.issn.1672-1756.2026.02.021

• 专科管理 • 上一篇    下一篇

非内分泌科持续皮下胰岛素输注患者全程血糖管理方案的应用

毕甜甜 吕学玲 张老追 李丽艳 孙丽丽 徐仁华   

  1. 滨州医学院护理学院,264003 山东省烟台市(毕甜甜,孙丽丽,徐仁华);东营市第二人民医院(毕甜甜,吕学玲,张老追,李丽艳)
  • 出版日期:2026-02-15 发布日期:2026-02-15
  • 通讯作者: 徐仁华,博士,教授,E-mail:xrhazz@163.com
  • 作者简介:毕甜甜,硕士在读,主管护师
  • 基金资助:
    山东省社会科学规划研究项目(21CGLJ01)

Practice of whole-process blood glucose management for patients undergoing Continuous Subcutaneous Insulin Infusion therapy in non-endocrinology departments based on in-hospital grid management

BI Tiantian, LYU Xueling, ZHANG Laozhui, LI Liyan, SUN Lili, XU Renhua   

  1. School of Nursing, Binzhou Medical University, Yantai, Shandong province, 264003, China
  • Online:2026-02-15 Published:2026-02-15
  • Contact: E-mail:xrhazz@163.com

摘要: 目的:构建非内分泌科持续皮下胰岛素输注(Continuous Subcutaneous Insulin Infusion,CSII)患者全程血糖管理方案并评价其效果,为改善患者血糖管理水平提供参考。方法:采用类实验研究设计,便利选取东营市某三级乙等医院200例非内分泌科CSII患者为研究对象,以2024年1月—6月治疗的100例患者为对照组,实施常规血糖管理;以2024年7月—12月治疗的100例患者为干预组,实施基于院内网格化管理的全程血糖管理方案。比较两组患者CSII治疗期间平均血糖达标时间、院内和院外低血糖发生率、出院后3个月糖化血红蛋白(Glycated Hemoglobin A1c,HbA1c)达标率、门诊复诊率、患者满意度。结果:干预组患者CSII治疗期间平均血糖达标时间为(3.62±0.96)天、对照组为(4.74±1.26)天,差异有统计学意义(P<0.05);干预组患者院内和院外低血糖发生率低于对照组,干预组患者出院后3个月HbA1c达标率、门诊复诊率、患者满意度高于对照组,差异均有统计学意义(P<0.05)。结论:基于院内网格化管理的全程血糖管理方案可改善非内分泌科CSII患者血糖水平,降低低血糖风险,提高复诊率及满意度。

关键词: 持续皮下胰岛素输注;网格化管理;全程管理;血糖管理;模式

Abstract: Objective: To develop a whole-process blood glucose management protocol for patients undergoing Continuous Subcutaneous Insulin Infusion (CSII) therapy in non-endocrinology departments based on in-hospital grid management and to explore its effects, so as to provide a reference for improving patients' blood glucose management. Methods: A quasi-experimental study design was adopted. The convenience sampling was used to recruit 200 patients receiving CSII therapy in non-endocrinology departments from a tertiary grade B hospital in Dongying. A total of 100 patients treated with CSII from January to June 2024 were assigned to the control group, receiving routine blood glucose management; another 100 patients treated with CSII from July to December 2024 were assigned to the intervention group, receiving whole-process blood glucose management based on in-hospital grid management. The average time to blood glucose control during CSII therapy, incidence of hypoglycemia, the Glycated Hemoglobin A1c (HbA1c) control rate 3 months after discharge, the outpatient revisit rate, and the patient satisfaction were compared between the two groups. Results: The average time to blood glucose control during CSII treatment for patients in the intervention group was 3.62±0.96 days, while that of the control group was 4.74±1.26 days, the incidence of in-hospital and out-of-hospital hypoglycemia for patients in the intervention group were both lower than those of the control group, the HbA1c control rate 3 months after discharge, the outpatient revisit rate, and the patient satisfaction for patients in the intervention group were all higher than those of the control group, all differences were statistically significant (P<0.05). Conclusion: Whole-process blood glucose management based on in-hospital grid management can improve blood glucose control indicators, reduce the risk of hypoglycemia, and increase the outpatient revisit rate and patient satisfaction among patients undergoing CSII therapy in non-endocrinology departments.

Key words: Continuous Subcutaneous Insulin Infusion; grid management; whole-process management; blood glucose management; model

中图分类号:  R47;R197